Literature DB >> 8133900

Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways.

N Adham1, L A Borden, L E Schechter, E L Gustafson, T L Cochran, P J Vaysse, R L Weinshank, T A Branchek.   

Abstract

We recently described the cloning of a fifth member of the 5-hydroxytryptamine (5-HT)1 (serotonin1) receptor class that inhibits adenylyl cyclase, namely the human 5-HT1F receptor (Adham et al. 1993a). In the present study we have examined in greater detail the functional coupling of the 5-HT1F receptor in two different cell lines, NIH-3T3 and LM(tk-) fibroblasts (receptor densities of 1.7 and 4.4 pmol/mg protein, respectively). The maximal inhibitory response elicited by 5-HT was significantly greater in NIH-3T3 as compared to LM(tk-) cells, whereas the EC50 values were comparable. To investigate the relationship between receptor occupancy and inhibition of cAMP accumulation mediated by 5-HT1F receptors in NIH-3T3 cells (and hence the degree of receptor reserve), we used the irreversible receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). The half-maximal response required only about 10% receptor occupancy, consistent with a receptor reserve of 90% (88 +/- 2.1%, n = 4) for 5-HT-induced inhibition of FSCA. Despite the presence of such a high degree of receptor reserve, a range of intrinsic activities was displayed by structurally diverse classes of compounds. For example, sumatriptan and lysergol were as efficacious as 5-HT itself and thus acted as full agonists, whereas metergoline and 1-NP behaved as partial agonists and as shown previously (Adham et al. 1993a), methiothepin was a silent antagonist (Kb = 438 nM). We have also investigated activation of additional signal transduction pathways by the 5-HT1F receptor and found that the responses differ in the two cell lines with respect to stimulation of phospholipase C. For example, in NIH-3T3 cells no elevation of inositol phosphates (IP) of [Ca2+]i was observed even at very high agonist concentrations (100 microM). In contrast, in LM(tk-) cells concentrations of 5-HT as low as 10 nM induced stimulation of IP and a rapid increase of [Ca2+]i. The 5-HT1F receptor failed to alter arachidonic acid release in either cell line. The maximal increase in IP accumulation in LM(tk-) cells was modest, averaging about 100% above basal. The increases of IP and [Ca2+]i required 5-HT concentrations less than one order of magnitude greater than those inhibiting FSCA (EC50 = 17, 55 and 8 nM, respectively), and both responses were blocked by 100 microM methiothepin. All three responses (cAMP, IP, and [Ca2+]i) were sensitive to pertussis toxin pre-treatment, suggesting the involvement of Gi/Go protein(s) in these signal transduction pathways.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133900     DOI: 10.1007/bf00167231

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  52 in total

Review 1.  The molecular biology of serotonin receptors. An overview.

Authors:  P Hartig; H T Kao; M Macchi; N Adham; J Zgombick; R Weinshank; T Branchek
Journal:  Neuropsychopharmacology       Date:  1990 Oct-Dec       Impact factor: 7.853

2.  An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover.

Authors:  A Ashkenazi; J W Winslow; E G Peralta; G L Peterson; M I Schimerlik; D J Capon; J Ramachandran
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

3.  Cell-specific signaling of the 5-HT1A receptor. Modulation by protein kinases C and A.

Authors:  Y F Liu; P R Albert
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

Review 4.  Inositol trisphosphate and diacylglycerol: two interacting second messengers.

Authors:  M J Berridge
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells.

Authors:  B R Conklin; M R Brann; N J Buckley; A L Ma; T I Bonner; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.

Authors:  R Y Kanterman; L C Mahan; E M Briley; F J Monsma; D R Sibley; J Axelrod; C C Felder
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

7.  Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.

Authors:  N Adham; B Ellerbrock; P Hartig; R L Weinshank; T Branchek
Journal:  Mol Pharmacol       Date:  1993-03       Impact factor: 4.436

8.  Isolation of a mouse "5HT1E-like" serotonin receptor expressed predominantly in hippocampus.

Authors:  N Amlaiky; S Ramboz; U Boschert; J L Plassat; R Hen
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

9.  Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.

Authors:  N Adham; H T Kao; L E Schecter; J Bard; M Olsen; D Urquhart; M Durkin; P R Hartig; R L Weinshank; T A Branchek
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  G-protein beta gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2.

Authors:  D Kim; D L Lewis; L Graziadei; E J Neer; D Bar-Sagi; D E Clapham
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

View more
  11 in total

1.  Operational characteristics of the 5-HT1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs. Close resemblance to the 5-HT1D receptor subtype.

Authors:  C M Villalón; A Sánchez-López; D Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

Review 2.  5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?

Authors:  Lars Neeb; Jannis Meents; Uwe Reuter
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

3.  Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.

Authors:  J M Zgombick; L E Schechter; N Adham; S A Kucharewicz; R L Weinshank; T A Branchek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.

Authors:  P J Pauwels; C Palmier; T Wurch; F C Colpaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

5.  Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation.

Authors:  P L Durham; R V Sharma; A F Russo
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

6.  Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

Authors:  Y G Ni; N Camacho; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.

Authors:  C Waeber; M A Moskowitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

Review 8.  5-HT1A receptor-mediated apoptosis: death by JNK?

Authors:  Emanuel Meller
Journal:  Biochim Biophys Acta       Date:  2007-01-10

9.  Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.

Authors:  Z Razzaque; M A Heald; J D Pickard; L Maskell; M S Beer; R G Hill; J Longmore
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

10.  5-HT inhibition of rat insulin 2 promoter Cre recombinase transgene and proopiomelanocortin neuron excitability in the mouse arcuate nucleus.

Authors:  K Hisadome; M A Smith; A I Choudhury; M Claret; D J Withers; M L J Ashford
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.